Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Morhulin ointment
1302020F0BBAAAB
|
Morhulin | Cod liver oil | Skin | No data available |
|
Mycil Athlete's Foot 1% spray
1310020Y0BFADAJ
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycil ointment
1310020Y0BFABAG
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycil powder
1310020Y0BFACAH
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycota spray
1310020Z0BCADAK
|
Mycota | Undecenoates | Skin | No data available |
|
Neo Baby cream
130201000BBKWCX
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Neomycin 0.25% / Gramicidin 0.025% ointment
1310011P0AAAJAJ
|
Neomycin sulfate (Topical) | Neomycin sulfate | Skin | No data available |
|
Neutratop 0.75% gel
1310012K0BHAAAR
|
Neutratop | Metronidazole | Skin | No data available |
|
Nizorelle 1% shampoo
1309000I0BCAAAC
|
Nizorelle | Ketoconazole | Skin | No data available |
|
Noritate 1% cream
1310012K0BFAABJ
|
Noritate | Metronidazole | Skin | No data available |
|
Numark Antiseptic 0.5% cream
1310050D0BRAAAA
|
Numark (Cetrimide) | Cetrimide | Skin | No data available |
|
Numark Calamine lotion
1303000D0BGAAAC
|
Numark (Calamine) | Calamine | Skin | No data available |
|
Numark Cold Sore 5% cream
1310030C0BQAAAA
|
Numark (Aciclovir) | Aciclovir | Skin | No data available |
|
Nystan 100,000units/g ointment
1310020U0BDACAD
|
Nystan (Topical) | Nystatin | Skin | No data available |
|
Nystatin 100,000units/g / Tolnaftate 1% cream
1310020U0AAAGAG
|
Nystatin (Topical) | Nystatin | Skin | No data available |
|
Nystatin 100,000units/g ointment
1310020U0AAADAD
|
Nystatin (Topical) | Nystatin | Skin | No data available |
|
Oilatum Junior Flare-Up bath additive
1302011L0BEABAD
|
Oilatum Plus | Light liquid paraffin | Skin | No data available |
|
Oilatum lotion
130201000BBJXA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Omicur 5% medicated nail lacquer
1310020A0BDAAAA
|
Omicur | Amorolfine hydrochloride | Skin | No data available |
|
Otulfi 45mg/0.5ml solution for injection pre-filled syringes
1305030D0BGAAAB
|
Otulfi | Ustekinumab | Skin | No data available |
|
Otulfi 90mg/1ml solution for injection pre-filled syringes
1305030D0BGABAC
|
Otulfi | Ustekinumab | Skin | No data available |
|
Ovelle aqueous cream
130201100BBBDAM
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | No data available |
|
Ovelle Petroleum jelly white
1302010N0BHAAAA
|
Ovelle Petroleum jelly | Paraffin soft white | Skin | No data available |
|
Ovelle zinc and castor oil ointment
1302020E0BJAAAC
|
Ovelle zinc and castor oil | Zinc oxide | Skin | No data available |
|
OxBipp paste
131005000BBBXAE
|
Proprietary compound preparation BNF 1310050 | Other minor cut and abrasion preparations | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.